AIA Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,172
| Closed | -$413K | – | 348 |
|
2023
Q4 | $413K | Sell |
1,172
-214
| -15% | -$75.4K | 0.02% | 243 |
|
2023
Q3 | $520K | Sell |
1,386
-2,182
| -61% | -$819K | 0.03% | 214 |
|
2023
Q2 | $1.36M | Buy |
3,568
+3,207
| +888% | +$1.23M | 0.07% | 139 |
|
2023
Q1 | $125K | Hold |
361
| – | – | 0.01% | 357 |
|
2022
Q4 | $85K | Sell |
361
-468
| -56% | -$110K | 0.01% | 373 |
|
2022
Q3 | $204K | Sell |
829
-511
| -38% | -$126K | 0.01% | 292 |
|
2022
Q2 | $405K | Sell |
1,340
-65
| -5% | -$19.6K | 0.02% | 264 |
|
2022
Q1 | $577K | Buy |
1,405
+403
| +40% | +$166K | 0.03% | 216 |
|
2021
Q4 | $470K | Buy |
1,002
+238
| +31% | +$112K | 0.02% | 188 |
|
2021
Q3 | $324K | Buy |
764
+127
| +20% | +$53.9K | 0.02% | 212 |
|
2021
Q2 | $236K | Buy |
+637
| New | +$236K | 0.02% | 201 |
|